Evidence for leukocyte infiltration, ICAM-1 expression, permeability following ischemic paraplegia: Functional blocking of ICAM-1 as a new therapeutic target

Kamatham A. Naidu, E. Truitt Sutton, Eugene Fu, Leon D. Prockop

Research output: Contribution to journalArticle

Abstract

This study evaluates leukocyte infiltration, ICAM-1 expression, permeability across the blood-spinal cord barrier (BSCB)and therapeutic effect of ICAM-1 following epidural administration. Rabbits weighing ( 2.5 Kg) were anesthetized with halothane, an abdominal incision was made, the descending aorta exposed and occluded with an aneusysm clip. After varible periods of occlusion, the clip was removed and incision closed with sutures and skin clips. Sham-operated controls were prepared identically but descending aorta was not occluded. Following 2,4 and 8h after 30 min occlusion the following were evaluated in the lumbar cord: ICAM-1 expression by immunohistochemistry; leukocyte infiltration by electron microscopy; vascular endothelial permeability across BSCB by radiometry. The therapeutic efficacy of ICAM-1 MAb was tested by preemptive epidural administration of 0.5mg/Kg ICAM-1 MAb, following variable occlusion periods, i.e., 10,15.20,25 and 30 min. The neurological examination was performed 20h later on a Tarlov's scale in a blinded fashion. The ICAM-1 expression and leukocyte recruitment/infiltration were significantly increased following 8h after 30 min occlusion. The BSCB permeability of D-mannitol and inulin was significantly increased. The quantal response curve computed as dichotomous function of non-paraplegia/paraplegia Vs occlusion period based on neurologic evaluation, revealed that treatment with ICAM-1 MAb produced significant reduction in neurological deficits (P<0.05)in this model.

Original languageEnglish
JournalFASEB Journal
Volume12
Issue number5
StatePublished - Mar 20 1998
Externally publishedYes

Fingerprint

Paraplegia
Intercellular Adhesion Molecule-1
Infiltration
spinal cord
Permeability
leukocytes
permeability
Leukocytes
aorta
therapeutics
blood
radiometry
Spinal Cord
Surgical Instruments
inulin
halothane
sutures
Blood
mannitol
blood vessels

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Evidence for leukocyte infiltration, ICAM-1 expression, permeability following ischemic paraplegia : Functional blocking of ICAM-1 as a new therapeutic target. / Naidu, Kamatham A.; Sutton, E. Truitt; Fu, Eugene; Prockop, Leon D.

In: FASEB Journal, Vol. 12, No. 5, 20.03.1998.

Research output: Contribution to journalArticle

@article{1ae232b3081e4cf1acb74f4f04557389,
title = "Evidence for leukocyte infiltration, ICAM-1 expression, permeability following ischemic paraplegia: Functional blocking of ICAM-1 as a new therapeutic target",
abstract = "This study evaluates leukocyte infiltration, ICAM-1 expression, permeability across the blood-spinal cord barrier (BSCB)and therapeutic effect of ICAM-1 following epidural administration. Rabbits weighing ( 2.5 Kg) were anesthetized with halothane, an abdominal incision was made, the descending aorta exposed and occluded with an aneusysm clip. After varible periods of occlusion, the clip was removed and incision closed with sutures and skin clips. Sham-operated controls were prepared identically but descending aorta was not occluded. Following 2,4 and 8h after 30 min occlusion the following were evaluated in the lumbar cord: ICAM-1 expression by immunohistochemistry; leukocyte infiltration by electron microscopy; vascular endothelial permeability across BSCB by radiometry. The therapeutic efficacy of ICAM-1 MAb was tested by preemptive epidural administration of 0.5mg/Kg ICAM-1 MAb, following variable occlusion periods, i.e., 10,15.20,25 and 30 min. The neurological examination was performed 20h later on a Tarlov's scale in a blinded fashion. The ICAM-1 expression and leukocyte recruitment/infiltration were significantly increased following 8h after 30 min occlusion. The BSCB permeability of D-mannitol and inulin was significantly increased. The quantal response curve computed as dichotomous function of non-paraplegia/paraplegia Vs occlusion period based on neurologic evaluation, revealed that treatment with ICAM-1 MAb produced significant reduction in neurological deficits (P<0.05)in this model.",
author = "Naidu, {Kamatham A.} and Sutton, {E. Truitt} and Eugene Fu and Prockop, {Leon D.}",
year = "1998",
month = "3",
day = "20",
language = "English",
volume = "12",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "5",

}

TY - JOUR

T1 - Evidence for leukocyte infiltration, ICAM-1 expression, permeability following ischemic paraplegia

T2 - Functional blocking of ICAM-1 as a new therapeutic target

AU - Naidu, Kamatham A.

AU - Sutton, E. Truitt

AU - Fu, Eugene

AU - Prockop, Leon D.

PY - 1998/3/20

Y1 - 1998/3/20

N2 - This study evaluates leukocyte infiltration, ICAM-1 expression, permeability across the blood-spinal cord barrier (BSCB)and therapeutic effect of ICAM-1 following epidural administration. Rabbits weighing ( 2.5 Kg) were anesthetized with halothane, an abdominal incision was made, the descending aorta exposed and occluded with an aneusysm clip. After varible periods of occlusion, the clip was removed and incision closed with sutures and skin clips. Sham-operated controls were prepared identically but descending aorta was not occluded. Following 2,4 and 8h after 30 min occlusion the following were evaluated in the lumbar cord: ICAM-1 expression by immunohistochemistry; leukocyte infiltration by electron microscopy; vascular endothelial permeability across BSCB by radiometry. The therapeutic efficacy of ICAM-1 MAb was tested by preemptive epidural administration of 0.5mg/Kg ICAM-1 MAb, following variable occlusion periods, i.e., 10,15.20,25 and 30 min. The neurological examination was performed 20h later on a Tarlov's scale in a blinded fashion. The ICAM-1 expression and leukocyte recruitment/infiltration were significantly increased following 8h after 30 min occlusion. The BSCB permeability of D-mannitol and inulin was significantly increased. The quantal response curve computed as dichotomous function of non-paraplegia/paraplegia Vs occlusion period based on neurologic evaluation, revealed that treatment with ICAM-1 MAb produced significant reduction in neurological deficits (P<0.05)in this model.

AB - This study evaluates leukocyte infiltration, ICAM-1 expression, permeability across the blood-spinal cord barrier (BSCB)and therapeutic effect of ICAM-1 following epidural administration. Rabbits weighing ( 2.5 Kg) were anesthetized with halothane, an abdominal incision was made, the descending aorta exposed and occluded with an aneusysm clip. After varible periods of occlusion, the clip was removed and incision closed with sutures and skin clips. Sham-operated controls were prepared identically but descending aorta was not occluded. Following 2,4 and 8h after 30 min occlusion the following were evaluated in the lumbar cord: ICAM-1 expression by immunohistochemistry; leukocyte infiltration by electron microscopy; vascular endothelial permeability across BSCB by radiometry. The therapeutic efficacy of ICAM-1 MAb was tested by preemptive epidural administration of 0.5mg/Kg ICAM-1 MAb, following variable occlusion periods, i.e., 10,15.20,25 and 30 min. The neurological examination was performed 20h later on a Tarlov's scale in a blinded fashion. The ICAM-1 expression and leukocyte recruitment/infiltration were significantly increased following 8h after 30 min occlusion. The BSCB permeability of D-mannitol and inulin was significantly increased. The quantal response curve computed as dichotomous function of non-paraplegia/paraplegia Vs occlusion period based on neurologic evaluation, revealed that treatment with ICAM-1 MAb produced significant reduction in neurological deficits (P<0.05)in this model.

UR - http://www.scopus.com/inward/record.url?scp=33749320660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749320660&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749320660

VL - 12

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 5

ER -